Kimberly Lin, MD

Dr. Lin’s clinical research focus is on children and young adults with cardiomyopathy and risk of heart failure. As medical director of the Pediatric Cardiomyopathy Program at the Children’s Hospital of Philadelphia, she oversees our multidisciplinary efforts aimed at the early detection and treatment of the heart disease that can accompany conditions as diverse as Noonan syndrome, Duchenne Muscular Dystrophy (DMD), Friedreich Ataxia (FRDA), end stage renal disease, transplant vasculopathy, and non-syndromic hypertrophic cardiomyopathy. The use of exercise as a means of improving outcomes and measuring meaningful functional capacity in children with heart conditions is an area of particular interest to Dr. Lin. She is a co-investigator on an R01 grant from the NHLBI exploring the combined effects of an individualized exercise training regimen and an oral exercise mimetic on patients with FRDA, as well as a second R01 grant from the NCI evaluating a similar intervention in hematopoietic stem cell survivors. Their group has successfully implemented a combination aerobic + resistance training regimen using adaptive equipment for FRDA patients and looks forward to analyzing and publishing results from this cohort in the near future.